logo-loader

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Last updated: 04:30 08 May 2019 BST, First published: 14:30 07 May 2019 BST

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.
 
Hall says there has been a shortfall in the standard of quality healthcare today and Medlab is looking to provide better new health solutions.
 
The company is doing extensive work exploring the role gut health plays in chronic illnesses and developing quality nutraceuticals, popular treatments that contributed towards Medlab's revenue milestones last month.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

35 minutes ago